The QualityStocks Daily Tuesday, March 24th, 2020

Today's Top 3 Investment Newsletters

StockMarketWatch (IMAC) +1,025.18%

QualityStocks (OSSPF) +124.36%

Broad Street (USAU) +122.89%

The QualityStocks Daily Stock List

Armanino Foods of Distinction, Inc. (AMNF)

Zacks, InvestorDeck, Dividend Diplomats, Super Stock Screener, Market Screener, QSR Magazine, Wallet Investor, InvestorsHub, Capital Cube, OTC Markets, TalkMarkets, StockInvest.us, hot Stocked, Infront Analytics, MarketBeat, Morningstar, TMXmoney, Simply Wall St, MarketWatch, GuruFocus, Dividend.com, Dividend Investor, TradingView, Seeking Alpha and Investing.com reported earlier on Armanino Foods of Distinction, Inc. (AMNF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Armanino Foods of Distinction, Inc. produces and markets frozen and refrigerated food products in the United States. The Company offers its products under the Armanino brand. It markets its products through a network of food brokers. In addition, it sells to retail and foodservice distributors, club-type stores and industrial accounts. Formed in 1978, Armanino Foods of Distinction has its corporate headquarters in Hayward, California.

Armanino’s frozen products consist of pesto sauces, stuffed pastas, and pasta sheets. They also include Italian pastas and cooked meat products. The Company also offers cooked beef and turkey meatballs, and cheese shakers; and cooked and uncooked frozen stuffed pastas. This includes meat, butternut squash, cheese ravioli and jumbo cheese, and jumbo mushroom ravioli. Armanino also offers jumbo cheese/spinach green dough ravioli; cheese ravioli; meat filled, tri-color cheese, and cheese tortellini; and tri-color cheese and cheese capelletti, manicotti, and stuffed shells.

In the Foodservice sector, Armanino Foods of Distinction is the industry’s foremost source for premium frozen pesto. Armanino is famous for its Basil Pesto. Moreover, the Company offers other flavors including Cilantro, Dried Tomato & Garlic, Roasted Red Bell Pepper, Southwest Chipotle, Artichoke, Roasted Garlic, Creamy Garlic, Harissa, Romesco, Chimichurri, and Light Basil Pesto.

Last month, Armanino Foods of Distinction reported record-breaking sales and earnings for Q4 and for the year ended December 31, 2019. Net Sales for Q4 of 2019 were $10,929,061 versus $10,265,532 for the prior year. This represents an increase of 6 percent.

Income before Taxes for Q4 2019 were $1,795,737 versus $1,670,855 for the same quarter in 2018. This represents an increase of 7 percent. Net Income for this period rose to $1,422,805 (or $0.0444 per share), from $1,230,706 (or $0.0384 per share) for the prior year. This represents an increase of 16 percent.

Net Sales for the year ended December 31, 2019 were $42,551,202 versus $41,838,018 for 2018. This represents an increase of 2 percent. Income before Taxes for 2019 were $8,181,402, versus the 2018 figure of $8,126,086. This represents an increase of 1 percent. Net Income for the year ended December 31, 2019 was $6,484,997 (or $0.2022 per share), versus $6,265,786 (or $0.1954 per share) for 2018, an increase of 3 percent.

Armanino Foods of Distinction, Inc. (AMNF), closed Tuesday’s trading session at $2.26, up 10.2439%, on 54,116 volume. The average volume for the last 3 months is 35,081 and the stock's 52-week low/high is $1.75/$3.79250001.

chart

Ayr Strategies, Inc. (AYRSF)

NetworkNewsWire, Investment Pitch, Smarter Analyst, TipRanks, NIC Investors, Midas Letter, OTC.Watch, Barchart, Market Screener, mg retailer, InvestorX, Investing News, Dividend Investor, Analyst Ratings, GlobeNewswire, OTC Markets, Stockwatch, TradingView, GuruFocus, Seeking Alpha, InvestorsHub and Stockhouse reported beforehand on Ayr Strategies, Inc. (AYRSF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Ayr Strategies, Inc. is a vertically-integrated cannabis multi-state operator (MSO) with a presence in the western and eastern United States. It focuses on high-growth markets and has anchor operations in Massachusetts and Nevada. Ayr cultivates and manufactures branded cannabis products for distribution via its network of retail outlets and through third-party stores. Ayr Strategies has its head office in New York, New York. The Company’s shares trade on the OTC Markets Group’s OTCQX.

The Company’s growth plan is centered on established businesses, best-in-class operators. Regarding its M&A (Mergers & Acquisitions) strategy, Ayr targets limited license States to cluster and penetrate, building regional clusters and brand strength. The Company’s focus is on profitability and cash flow. Ayr has five operating companies.

This past December, Ayr Strategies announced it received final license approval from the Cannabis Control Commission (CCC) to grow cannabis in its earlier completed cultivation facility, as disclosed by the CCC on December 19, 2019. This is Ayr’s second cultivation facility in Milford, Massachusetts.

The Company completed its expansion plans in November 2019 to create one of the largest cultivation facilities in Massachusetts. It was solely awaiting approval from the CCC to grow cannabis in the new space. Ayr sells its products to retail and wholesale customers throughout Massachusetts. Its products are now available at 55 percent of dispensaries in the State. Ayr was the first licensed cannabis company in the State to resume vape cartridge sales (following the lifting of the temporary ban) for its dispensaries and at the wholesale level beginning, December 19, 2019.

Today, Ayr Strategies announced it filed its audited 2019 annual financial statements on SEDAR. Company Chief Executive Officer, Mr. Jonathan Sandelman, said, “We remain on track to begin sales from our recently expanded cultivation in Massachusetts and Nevada, where we more than doubled our canopy from 27,000 square feet to 63,000 square feet. Combined with our strong balance sheet and ongoing cash flow generation, we are well-positioned to deliver strong growth in 2020.”

Ayr Strategies, Inc. (AYRSF), closed Tuesday’s trading session at $4.99, up 27.9487%, on 90,267 volume. The average volume for the last 3 months is 25,350 and the stock's 52-week low/high is $3.44000005/$19.7000007.

chart

Cheetah Mobile, Inc. (CMCM)

Stock Twits, Street Insider, PR Newswire, Zacks, Investing.com, AlphaQuery, Infront Analytics, YCharts, Stockopedia, Simply Wall Street, InvestorsHub, Seeking Alpha, Stockhouse, last10k, Barchart, Insider Monkey, Morningstar, MacroTrends, GuruFocus, and CSI Market reported previously on Cheetah Mobile, Inc. (CMCM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Cheetah Mobile, Inc. is a foremost mobile internet company with global market coverage. It provides its advertising customers, which include direct advertisers and mobile advertising networks through which advertisers place their advertisements, with direct access to highly targeted mobile users and worldwide promotional channels. Cheetah Mobile’s dedication is to leveraging its inventive artificial intelligence (AI) technologies to power its products and make the world smarter.

The Company formerly went by the name Kingsoft Internet Software Holdings Limited. It changed its name to Cheetah Mobile, Inc. in March of 2014. Cheetah Mobile is based in Beijing, China.

Cheetah Mobile has attracted hundreds of millions of monthly active users through its mobile utility products such as Clean Master and Cheetah Keyboard, casual games such as Piano Tiles 2, Bricks n Balls, and live streaming product LiveMe. Additionally, the Company provides value-added services to its mobile application users through the sale of in-app virtual items on selected mobile products and games.

Cheetah Mobile has established a new business style. The Company’s traditional mobile Internet service with utility Apps and Internet entertainment as its heart is steadily producing cash flow. The AI-driven industrial Internet business has completed in building its technology and products and is prepared to enter the commercial phase. Cheetah Mobile’s commitment is to making AI robots the first truly smart offline device in business-based scenarios in the new era.

The Orion Star AI-driven robot, equipped with Cheetah Mobile’s smart solution, has been applied in more than 20 scenarios, providing services of smart navigation, smart shopping guide, smart civil affairs, and smart conferences. Moreover, the Company’s AItoC business has completed the technological development through technical empowerment, and has produced popular products.

Today, Cheetah Mobile announced its unaudited consolidated financial results for Q4 and full year ended December 31, 2019. Total Revenues were RMB612.0 million ( US$87.9 million ) in Q4 of 2019, decreasing by 55.7 percent year over year. Excluding the impact resulting from the deconsolidation of LiveMe's revenues, Total Revenues decreased by 46.9 percent year over year in Q4 of 2019.

Net Loss Attributable to Cheetah Mobile shareholders was RMB821.2 million ( US$118.0 million ) in Q4 of 2019, versus a Net Income Attributable to Cheetah Mobile shareholders of RMB733.3 million in Q4 of 2018.

Mr. Sheng Fu , Cheetah Mobile's Chairman and Chief Executive Officer, stated, "We are currently facing some difficulties in our legacy mobile internet business. However, these challenges are not causing any damage to our company at the systemic level. Over the past years, we have built an unyielding and relentless team while amassing a strong balance sheet. Importantly, the recent outbreak of COVID-19 has increased customer demand for our robotics products and solutions, while robotics business will not generate significant revenues in the near term. Going forward, we are confident in our ability to rejuvenate growth in our business by capturing those opportunities emerging in the field of artificial intelligence."

Cheetah Mobile, Inc. (CMCM), closed Tuesday’s trading session at $2.04, off by 3.3175%, on 1,109,841 volume with 4 trades. The average volume for the last 3 months is 375,818 and the stock's 52-week low/high is $1.88999998/$6.86000013.

chart

Elron Electronic Industries Ltd. (ELRNF)

Zacks, Nasdaq, OTC Markets, Market Screener, Morningstar, YCharts, Dividend Investor, MacroTrends, Stocktwits, PR Newswire, Wallet Investor, Research and Markets, last10k, Equity Clock, Seeking Alpha, GuruFocus, and TipRanks reported beforehand on Elron Electronic Industries Ltd. (ELRNF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Elron Electronic Industries Ltd.’s corporate vision is identifying transformative technologies, nurturing gifted entrepreneurs, and building companies into technology leaders. The Company, via its subsidiaries, provides technology products in the medical devices and cyber fields. Elron focuses its investments in fields where it brings added value and are able to facilitate opportunities. The Company was established in 1962 by Uzia Galil. Elron Electronic Industries is headquartered in Tel Aviv, Israel.

The Company specializes in early-stage investments with significant exit potential. Elron relies on a proven strategy of hands-on involvement in the day-to-day operations of its group companies.

Elron Electronic Industries offers BrainsGate, a minimally invasive treatment for ischemic stroke; Pocared, an automated microbiology lab system for infectious diseases diagnosis; CartiHeal implants for cartilage and bone repair in weight bearing joints; Coramaze, a transfemoral mitral valve repair system with atraumatic anchoring; and Notal Vision, a remote monitoring of patients at risk of vision loss from age-related macular degeneration. It also offers a cyber intelligence platform that detects and defuses threats before they become cyberattacks; Alcide, a dev-to-production security tool for workloads running on kubernetes platforms; and SecuredTouch a behavioral biometrics for mobile transactions, among other offerings.

Regarding medical devices, Elron invests in treatment-changing (rather than treatment-enhancing) medical device companies. It looks for companies with billion-$ market potential and it typically invests in the idea/R&D stage. Concerning cyber, the Company looks for investment opportunities from seed to growth stages.

Elron has its RDC Strategic JV (Joint Venture). In 1993, RDC was founded by Elron and Rafael, an international leader of defense technologies and one of Israel's largest defense companies. RDC combines Rafael's scale and technological edge, with Elron's vast expertise in helping start-ups develop into leading technology companies. Via RDC, which has exclusive rights to commercialize Rafael's defense technologies in civilian markets, Elron initiates and develop new companies, and provides vital support from start to exit.

Elron Electronic Industries Ltd. (ELRNF), closed Tuesday’s trading session at $1.15, off by 5.7377%, on 2,050 volume. The average volume for the last 3 months is 3,503 and the stock's 52-week low/high is $1.14999997/$2.67499995.

chart

Evergold Corp. (EVGUF)

StocksCafe, PredictWallStreet, Morningstar, OTC Markets, Market Screener, Nasdaq, GuruFocus, Wallet Investor, InvestorsHub, Stockhouse and EOD Data reported earlier on Evergold Corp. (EVGUF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Evergold Corp. engages in the exploration and development of mineral properties in the Province of British Columbia (B.C.). The Company has been assembled by a team with a record of recent success in British Columbia, combining four 100 percent-owned properties in prime geological real estate from one of B.C.’s best-known geologists, C.J. Greig, with experienced management and a highly qualified Board of Directors. Evergold is well financed with a $3.45 million IPO (Initial Public Offering) in October of 2019. Evergold is headquartered in Toronto, Ontario.

The Company’s projects include Snoball, Golden Lion, Holy Cross, and Spanish Lake. Snoball is 100 percent owned, has helicopter access, and is a 3,545-hectare property. It is drill-ready and offers near-term discovery potential. Golden Lion is 100 percent owned and also has helicopter access. It is a 5,099-hectare property. It is also drill-ready and also offers near-term discovery potential.

Spanish Lake is 100 percent owned and has drive-on road access. It is a 1,573-hectare property that offers near-term discovery potential. Additionally, Holy Cross is 100 percent owned and has direct road access. It is an 1,872-hectare property and is drill-ready and also offers near-term discovery potential.

Snoball and Golden Lion are Evergold’s flagship properties. The Company’s pipeline properties are Holy Cross and Spanish Lake. The target type at Snoball is high grade vein-hosted gold-silver, replacement/skarn, and intrusion-related bulk tonnage. Concerning Snoball, Evergold believes it has found the source of a large, strong, gold-silver anomaly, up-slope of prior work. It intends to drill it this year.

The target type at Golden Lion is high grade, vein-hosted epithermal gold-silver, coppergold-silver replacement/skarn, and bulk tonnage copper-gold porphyry. The target type at Holy Cross is high grade and/or bulk-tonnage intrusion-related gold+/-silver+/-copper. The target type at Spanish Lake is high grade and bulk tonnage sediment-hosted vein gold.

Recently, President and Chief Executive Officer of Evergold, Mr. Kevin Keough, spoke on the Company's plans to drill in the summer of 2020. Mr. Keough noted that Snoball and Golden Lion are in the best mining jurisdiction in British Columbia. The commodity emphasis is primarily gold and to a lesser extent silver, and to some extent copper. The video can be viewed at: https://www.b-tv.com/evergold-drilling-in-2020-ceo-clip-90sec/

Evergold Corp. (EVGUF), closed Tuesday’s trading session at $0.215, up 19.4444%, on 1,000 volume. The average volume for the last 3 months is 4,661 and the stock's 52-week low/high is $0.146589994/$0.291880011.

chart

Lifeloc Technologies, Inc. (LCTC)

NetworkNewsWire, Promotion Stock Secrets, Real Investment Advice, Infront Analytics, Market Exclusive, Stockhouse, Wallet Investor, OTC Markets, AA Stocks, Stockopedia, last10k, OTC Dynamics, Stockwatch, InvestorsHub, Dividend Investor, Simply Wall St, and Market Wire News reported previously on Lifeloc Technologies, Inc. (LCTC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Lifeloc Technologies, Inc. is a global leader in the development and manufacturing of breath alcohol and drug testing devices. The Company is a manufacturer of evidential breath alcohol testers and related training and supplies for Workplace, Law Enforcement, Corrections and International customers. From its U.S. headquarters, Lifeloc designs, engineers and manufactures precision, fuel cell based, breath alcohol testing equipment for professional and personal use. Lifeloc Technologies is headquartered in Wheat Ridge, Colorado.

Lifeloc offers a complete line of Portable Breath Alcohol Testers (PBTs) and Evidential Breath Testers (EBTs). The Company is a single source for alcohol testing equipment, drug screening supplies, and education. It offers a complete range of models incorporating its patented alcohol detection and sensing algorithms and using its platinum fuel cell technology. It professional units are tested and approved by the National Highway Traffic Safety Administration (NHTSA), a part of the U.S. Department of Transportation (DOT), and manifold State forensic and international laboratories.

In the United States, Lifeloc Technologies supports its Workplace customers through a nationwide network of industry accredited and Lifeloc certified drug and alcohol training consultants. The Company assists organizations of all sizes in establishing and managing their drug and alcohol testing programs.

In 2019, Lifeloc Technologies released its second generation, patent protected EasyCal® calibration station. This new model is now capable of calibrating the entire line of Lifeloc professional breath alcohol testers. New features of the Company’s automated calibration station include RFID (radio frequency identification) registration of calibration gas standards. These features further automate the calibration process.

Additionally, in 2019, Lifeloc Technologies started the targeted release of its new platform breath alcohol testers, the LX9 and LT7. The LX9 adds new modes of communication. Moreover, the LX9 and LT7 have wide temperature use ranges and are readily configurable for custom usages. The LX9 and LT7 models were added to the U.S. Department of Transportation’s conforming product list in November of 2019.

This month, Lifeloc Technologies announced financial results for the 2019 fiscal year ended December 31, 2019. The Company posted Annual Net Revenue of $8.752 million resulting in 2019 After Tax Net Income of $626 thousand, or $0.26 per diluted share. These results compare to Net Revenue of $8.438 million for 2018, with Net Income of $217 thousand, or $0.09 per diluted share. The 2019 results include a one-time gain of $225 thousand from a licensing settlement.

Lifeloc Technologies, Inc. (LCTC), closed Tuesday’s trading session at $2.90, even for the day, on 10 volume. The average volume for the last 3 months is 865 and the stock's 52-week low/high is $2.20000004/$6.25.

chart

Osisko Mining, Inc. (OBNNF)

TipRanks, Smart Stock Trading Strategies, Barchart, Wallmine, Capital Cube, GuruFocus, Wallet Investor, Dividend.com, Resource World, Dividend Investor, Analyst Ratings, TradingView, 4-Traders, Market Screener, Morningstar, YCharts, Seeking Alpha and Stockhouse reported earlier on Osisko Mining, Inc. (OBNNF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Osisko Mining, Inc. is a mineral exploration company headquartered in Toronto, Ontario. The Company focuses on the acquisition, exploration, and development of precious metal resource properties in Canada. It holds a 100 percent interest in the high-grade Windfall gold deposit situated between Val-d’Or and Chibougamau in Québec. In addition, Osisko holds a 100 percent undivided interest in a large area of claims in the surrounding Urban Barry area and nearby Quévillon area (more than 2,700 square kilometers).

Osisko Mining lists on the OTC Markets. The Company previously went by the name Oban Mining Corporation. It changed its name to Osisko Mining, Inc. in June of 2016. Osisko Mining was incorporated in 2010.

Earlier this month, Osisko Mining provided new drilling results from the continuing definition and expansion drill program at its 100 percent owned Windfall gold project in the Abitibi greenstone belt, Urban Township, Eeyou Istchee James Bay, Québec. The program is presently centered on the Lynx deposit, exploration on the main mineralized zones, and deep exploration in the central areas of the mineralized intrusive system. Nineteen drills are active at Lynx and Triple Lynx.

Osisko Mining President and Chief Executive Officer, Mr. John Burzynski, said: “This first major set of new drill results following, and not included in, last month’s mineral resource estimate update continues to show high-grade results from Lynx in both infill and expansion holes. The drilling demonstrates very good potential for further growth of scale and grade at Lynx. While the focus of the drill program is on resource definition, the exploration team is excited about targeting several key areas of the Lynx deposit for growth potential, in particular a down-plunge projection where we believe Lynx Extension and Triple Lynx zones may intersect.”

Yesterday, Osisko Mining announced that in response to the order of the Government of Quebec to close all non-essential businesses until April 13, 2020, it has suspended operations at its Windfall gold project. To date, the Company has had no suspected or confirmed cases of COVID-19, and has had a COVID-19 protocol in place since March 11 to protect its workforce.

Osisko Mining, Inc. (OBNNF), closed Tuesday’s trading session at $1.585, up 15.8118%, on 614,106 volume. The average volume for the last 3 months is 217,978 and the stock's 52-week low/high is $1.16999995/$3.23000001.

chart

Amazing Energy Oil and Gas, Co. (AMAZ)

Proactive Investors, Investor Place, PR Newswire, Digital Journal, Energy Voice, Oil and Gas Investments Bulletin, Money Morning, Nasdaq, wallstreet-online, Tech Know Bits, and OilandGas360 reported beforehand on Amazing Energy Oil and Gas, Co. (AMAZ), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Amazing Energy Oil and Gas, Co. engages in the exploration, development, and production of oil and gas in Texas and East New Mexico. The Company operates leaseholds in the Permian Basin where it holds the rights within a 70,000-acre leasehold in Pecos County, Texas and is surrounded by large independent oil and gas companies. Overall, Amazing controls greater than 75,000 acres between their rights in Pecos County, Texas and assets in Lea County, New Mexico, and Walthall County, Mississippi. The Company also provides oilfield services to oil and gas well owners. The independent oil and gas exploration and production Company is based in Plano, Texas. Amazing Energy Oil and Gas lists on the OTC Markets Group’s OTCQB.

Jilpetco is a wholly-owned subsidiary of Amazing Energy Oil and Gas. Jilpetco is an oilfield services company. It owns and operates drilling, completion, and workers rigs. Jilpetco also leases operational services equipment.

Additionally, Amazing Energy Oil and Gas holds 16,904 gross acres in Lea County, New Mexico that is held by production. The Company primarily engages in the acquisition and exploitation of oil and natural gas properties with an emphasis on well-defined plays containing stacked pay zones such as the San Andres, Devonian, Pennsylvanian and Wolfcamp.

In West Sawyer, Lea County, New Mexico, Company development highlights include 16,904 gross acres; 10,051 net acres; 56 percent average Working Interest (WI) and operatorship. Four horizontal wells have been drilled. Net Production = 32.4 BOPD.

Pertaining to Pecos County, Amazing’s position accounts for rights within 70,000 acres leasehold (about 100 sq. miles); 100 percent WI; 75 percent Net Revenue Interest (NRI). A total of 26 wells have been drilled on the property. These are either producing or in the process of being completed.

Amazing Energy Oil and Gas has acquired assets located in Walthall County, Mississippi known as the Denver Mint Project. The new assets consist of 900 acres of leasehold, 9 oil wells and a saltwater disposal well. These assets include associated production facilities and infrastructure vital to substantially increase the asset's current production profile.

Recently, Amazing Energy Oil and Gas announced that it launched a new subsidiary called Amazing Energy Technologies, LLC (AET). It has brought on experienced professional, Mr. Mark Moss to run the new subsidiary as its Chief Executive Officer. The newly created entity will concentrate on the recovery and monetization of stranded natural gas from Amazing's existing assets and neighboring peers who presently either sell at a loss or flare associated gas production in the process of oil recovery.

Amazing Energy Technologies (AET) will address the stranded gas puzzle through delivering associated production and stranded gas to onsite portable units developed to convert gas to electricity and power onboard mining facilities for Bitcoin. It plans to deploy the first units in its Permian Basin acreage in the Summer of 2020.

Amazing Energy Oil and Gas, Co. (AMAZ), closed Tuesday’s trading session at $0.039, up 95.00%, on 270,251 volume. The average volume for the last 3 months is 151,958 and the stock's 52-week low/high is $0.008899999/$0.310000002.

chart

Harvest Oil & Gas Corp. (HRST)

Real Investment Advice, OilBlockChain.News, OTC Markets, OilandGas360, TipRanks, EnergyNow.com, MarketWatch, Nasdaq, Last10k, TradingView, Investing.com, YCharts, GuruFocus, GlobeNewswire, Barchart, Simply Wall St, Wallet Investor, Dividend Investor, Market Screener, Stockwatch, and Dividend.com reported earlier on Harvest Oil & Gas Corp. (HRST), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Harvest Oil & Gas Corp. is an independent oil and natural gas company listed on the OTC Markets’ OTCQX. It engages in the development and production of oil and natural gas properties in the United States. On June 4, 2018, EV Energy Partners, L.P., successfully completed its financial restructuring and emerged from Chapter 11 of the U.S. Bankruptcy Code as Harvest Oil & Gas Corp. Established in 2006, Harvest Oil & Gas has its corporate headquarters in Houston, Texas.

Harvest Oil & Gas’ assets consist mainly of producing and non-producing properties in the Barnett Shale, the Appalachian Basin (includes the Utica Shale), Michigan, the Mid-Continent areas in Oklahoma, Texas, Kansas and Louisiana, the Permian Basin, and the Monroe Field in Northern Louisiana. The Company’s oil and natural gas properties include 545 Bcfe of estimated net proved reserves situated in Kansas, Louisiana, Michigan, New Mexico, Ohio, Oklahoma, Pennsylvania, Texas and West Virginia. Since January of this year, Harvest sold all interests in the San Juan Basin representing 157.6 Bcfe and certain interests in the Mid-Continent area representing 9.5 Bcfe.

In September, Harvest Oil & Gas announced that it completed the earlier announced sales of Barnett Shale assets and certain Mid-Continent area assets positioned in the Anadarko Basin and SCOOP/STACK. Furthermore, the Company plans to enter into a new credit facility and is initiating a strategic review process. It is undertaking a review of strategic alternatives and has engaged Intrepid Partners, LLC to assist it in the process.

The comprehensive review will include, but not be limited to, the potential divestiture of additional assets or all of Harvest’s remaining assets and a potential sale or merger of the Company. Harvest Oil & Gas will also be reviewing options to decrease its overall cost structure to more closely align with the pro forma asset base after the Barnett and Mid-Continent divestitures.

Harvest Oil & Gas Corp. (HRST), closed Tuesday’s trading session at $3.75, up 78.5714%, on 6,936 volume. The average volume for the last 3 months is 3,962 and the stock's 52-week low/high is $2.0999999/$17.8500003.

chart

Windtree Therapeutics, Inc. (WINT)

Super Stock Screener, Investing Note, Modest Money, Investors Village, Simply Wall St, MacroTrends, Infront Analytics, Clay Trader, AI StockFinder, OTC Markets, Insider Financial, Marketbeat, Investors Hangout, InvestorsHub, Insider Tracking, PR Newswire, Zacks, Barchart, Market Screener, Biz Journals, Annual Reports, Stockhouse, and Wallet Investor reported previously on Windtree Therapeutics, Inc. (WINT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Windtree Therapeutics, Inc. is a clinical-stage, biopharmaceutical and medical device company listed on the OTC Markets’ OTCQB. The Company focuses on the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. Windtree has four programs in clinical development and numerous pre-clinical programs that span respiratory and cardiovascular disease states. Windtree Therapeutics is headquartered in Warrington, Pennsylvania.

Three of the Company’s clinical programs are in late-stage development. They include AEROSURF®, a unique combination drug/device product candidate designed to deliver Windtree's proprietary synthetic, peptide-containing surfactant non-invasively to premature infants with respiratory distress syndrome (RDS).

Windtree also has its istaroxime, a novel, dual-acting agent undergoing development to improve cardiac function in patients with acute heart failure while avoiding the unwanted side effects of existing treatments. The Company also has its rostafuroxin, a novel precision drug product undergoing development to target hypertensive patients with certain genetic profiles in the important group of patients with resistant hypertension.

Furthermore, Windtree Therapeutics has manifold pre-clinical products. This includes potential heart failure therapies delivered orally that are founded on SERCA2a mechanism of action.

This past December, Windtree Therapeutics and CVie Investments Limited, together with its wholly-owned subsidiary, CVie Therapeutics Limited, a privately-held company centered on developing drugs to treat cardiovascular diseases, announced the closing of a definitive agreement for the merger of a Windtree Therapeutics subsidiary and CVie in an all-stock transaction. The combined company retains the name Windtree Therapeutics. It will be a fully-integrated and diversified acute care company with mid-to-late clinical stage product assets and multiple preclinical assets and programs. Led by Windtree management, the merged company will continue to be based in Warrington, Pennsylvania, with pre-clinical operations in Taipei, Taiwan, and Milan, Italy.

Recently, Windtree Therapeutics announced the results of a new post-hoc analysis of previously released Phase 2 data, which suggests AEROSURF® may decrease the overall incidence and severity of bronchopulmonary dysplasia (BPD) in premature infants with respiratory distress syndrome (RDS), regardless of whether or not the infant was ultimately intubated. The new data were recently presented at the Pediatric Academic Societies (PAS) Meeting, the foremost event for academic pediatrics and child health research.

Windtree Therapeutics, Inc. (WINT), closed Tuesday’s trading session at $3.19, up 59.5%, on 1,943 volume. The average volume for the last 3 months is 1,304 and the stock's 52-week low/high is $1.50010001/$4.98999977.

chart

Osprey Gold Development Ltd. (OSSPF)

Stock Orange, Stockhouse, InvestorsHub, 4-Traders, OTC Markets, Morningstar, MarketWatch, GuruFocus, Junior Mining Network, Investing News, The Street, Seeking Alpha, and WatchDog Stocks reported earlier on Osprey Gold Development Ltd. (OSSPF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Osprey Gold Development Ltd. centers on exploring five historically producing gold properties in the Province of Nova Scotia. The Company’s flagship project is Goldenville in the historical mining district Goldenville, which is one of eastern Canada’s most significant gold belts. Osprey Gold has the option to earn 100 percent (subject to certain royalties) in all five properties. This includes the Goldenville Gold Project. Osprey Gold Development is headquartered in Vancouver, British Columbia.

The Goldenville Gold Project has an updated NI 43-101 inferred resource, which includes 2,800,000 tonnes at 3.20 g/t gold for a total of 288,000 ounces of gold (2.8 mil tonnes at 4.96 g/t gold for 447,000 ounces of gold uncapped). In addition, Osprey Gold Development is exploring the past producing Lower Seal Harbour, Miller Lake, Caribou, and Gold Lake gold projects.

Osprey entered into a definitive agreement wherein it acquired an option to acquire the Caribou Gold Property from John Logan Enterprises Ltd. With the Option Agreement, the Company may acquire a 100 percent interest (subject to certain royalties) in 16 contiguous mining claims (256 hectares) hosting the past-producing Caribou Property.

The Miller Lake Project is roughly 14 kilometers from Goldenville. It has historic production and limited recent exploration. The Gold Lake Project is approximately 70 kilometers northeast of Halifax. It was discovered in 1867 with minor production occurring in the late 1800’s.

The Caribou Gold property is 80 kilometers northwest of Halifax, Nova Scotia and 10 kilometers south of the rural community of Upper Musquodoboit, in Halifax County. The Caribou property contains an historic gold deposit that was intermittently mined between 1869 and 1955.

The Lower Seal Harbour project is in Guysborough County, Nova Scotia. This property is about 35 kilometers from Goldenville. Gold at Lower Seal Harbour is found in the veins and the host rocks.

Osprey Gold provided this past November more results from its exploration program at the Caribou Gold Project. The results provide continued evidence of lower grade disseminated mineralization within the host sediments, around the historically sampled high grade veins. The best reported intercept was hole CM87-23 reporting 70.57 meters (m) of 1.58 grams per tonne gold (g/t Au), or 0.80 g/t Au if utilizing a 70 g/t Au grade cap. Seven holes were sampled from four key areas for a total of 395 samples submitted for analysis.

At the end of December 2018, Osprey Gold reported that it closed its earlier announced non-brokered private placement of 1,334,000 flow through units (FT Units) of Osprey Gold at a price of $0.075 per unit, for total proceeds of $100,050. Each unit comprises one common share and one-half of one share purchase warrant, each whole warrant entitling the holder to purchase an additional common share at a price of $0.12 per share for a period of 18 months from date of issuance. Net proceeds of the private placement will be used for exploration and advancement of the Company’s exploration projects in Nova Scotia and general working capital.

Osprey Gold Development Ltd. (OSSPF), closed Tuesday’s trading session at $0.035, up 124.359%, on 288,620 volume. The average volume for the last 3 months is 107,099 and the stock's 52-week low/high is $0.014999999/$0.081395.

chart

Thunder Energies Corporation (TNRG)

Wallet Investor, Morningstar, YCharts, The Street, Stockwatch, Market Exclusive, Investor Place, The Silicon Review, InvestorsHub, Emerging Growth, Penny Stock Tweets, Penny Stock Hub, ResearchPool, Capital Cube, The Stock Radio, and Marketbeat reported previously on Thunder Energies Corporation (TNRG), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Thunder Energies Corporation concentrates on the manufacture, sale, and service of diverse technologies in the U.S. The Company previously went by the name Thunder Fusion Corporation. In May 2014, it changed its corporate name to Thunder Energies Corporation. Listed on the OTC Markets, Thunder Energies is based in Tarpon Springs, Florida.

The Company markets its technologies via three divisions. These are Optical Instruments, Combustion Equipment, and Nuclear Instruments. Concerning the Division of Optical Equipment, its emphasis is the production, promotion, sale and service of pairs of Galileo telescopes with convex lenses to detect matter-galaxies & Santilli telescopes with concave lenses to detect antimatter-galaxies (international patent pending).

Regarding the Division of Combustion Equipment, its focus is the production, promotion, sale and service of the novel HyperFurnace that attains the total combustion of fossil fuels and an enhanced energy output (patented and international patents pending).

Pertaining to the Division of Nuclear Equipment, the production, promotion, sale and service of the Santilli Thermal Neutron Source is based on a novel synthesis of the neutron from a hydrogen gas (international patent pending).

Thunder Energies’ Division of Combustion is successfully continuing the development of the new chemical species of gas named MagneHydrogen. The Company has secured the required domain names, has applied for available trademark protections and is finalizing engineering schematics for the first production of MagneHydrogen, separated from commercially available MagneGas through standard Pressure Swing Absorption equipment.

Thunder Energies has announced the initiation of the construction of a prototype Precious Metal Detector. Funding is from the S1 registration on record with GHS Investments in New York. Dr. Ruggero M. Santilli, Thunder Energies’ Chief Executive Officer, stated, "I am pleased to announce that, thanks to the availability of funds, our Company has initiated works necessary for the construction of a prototype Precious Metal Detector based on our Directional Neutron Source…”

Recently, Thunder Energies announced the initiation of construction of its Precious Metal Detector in conformity with the recent upgrade of the Letter of Intent (LOI) for its test and use.

Dr. Ruggero M. Santilli stated, "I am pleased to report the initiation of construction of the prototype Thunder Energies Precious Metal Detector following completion of all background research… We are currently completing the design of the Directional Neutron Source needed in mining operations and look forward with great confidence to the successful completion of the project."

Thunder Energies Corporation (TNRG), closed Tuesday’s trading session at $0.029, up 93.3333%, on 15,000 volume. The average volume for the last 3 months is 22,206 and the stock's 52-week low/high is $0.011099999/$0.200000002.

chart

Innovative Food Holdings, Inc. (IVFH)

MissionIR, Penny Stock Tweets, Investors Hangout, Dividend Investor, Plunkett Research, Marketbeat, Equity Clock, StockInvest, Simply Wall St, Tip Ranks, Stockopedia, YCharts, The Bowser Report,  Stock Guru, FeedBlitz, Capital Cube, and Wallet Investor reported earlier on Innovative Food Holdings, Inc. (IVFH), and today we report on the Company, here at the QualityStocks Daily Newsletter. 

Innovative Food Holdings, Inc. is an industry leading specialty food platform. The Company, by way of its subsidiaries, is a foremost nationwide provider of direct from source specialty foods, healthcare foods, gluten free foods, and artisanal foods, to the professional foodservice market. Perishable product is delivered direct to the Company’s kitchen the next day via overnight delivery. Non-perishable product is delivered direct to customers. Innovative Food Holdings is headquartered in Bonita Springs, Florida.

For Chefs (Chef Direct), the Company’s vertically-integrated platform enables it to source 7,000-plus specialty foods worldwide and deliver within 24-72 hours. Innovative Food Holdings’ subsidiaries include Artisan Specialty Foods and Innovative Gourmet.

Artisan Specialty Foods is a nationwide specialty food distributer, re-packer, and importer. Artisan serves hundreds of customers in the Chicago area. In addition, Artisan serves as a nationwide fulfillment center for other Company subsidiaries operating in the foodservice and direct-to-consumer markets.

Innovative Food Holdings supplies chefs with innovative, organic, sustainable, and artisanal products sourced from all areas globally. The Company markets its  products directly to the consumer, through its website at www.forthegourmet.com/.

Innovative Food Holdings’ subsidiary, Innovative Gourmet, acquired substantially all the assets of one of North America’s leading online gourmet food and gift retailers in 2018. The business operates under igourmet’s valued and trusted trade name.

igourmet offers a broad assortment of high quality gourmet and specialty food products via www.igourmet.com, and through a complete line of omnichannel partners. Furthermore, igourmet offers a wide array of specialty food products to restaurants, specialty retailers and other business establishments through its specialty foodservice division.

Pertaining to Innovative Food Holdings’ customer service, the Company has dedicated Chef Advisors that are available by phone or email to assist customers. They provide assistance with additional product information, sourcing additional gourmet products, and menu consultation. They also provide assistance with application and complementing product suggestions and providing more specific delivery window estimates.

Innovative Food Holdings, Inc. (IVFH), closed Tuesday’s trading session at $0.32, up 88.2353%, on 207,306 volume. The average volume for the last 3 months is 44,901 and the stock's 52-week low/high is $0.150099992/$0.620500028.

chart

WRIT Media Group, Inc. (WRIT)

OTC Markets, InvestorsHub, MarketWatch, TradingView, Stockhouse, Marketbeat, and Barchart  reported on WRIT Media Group, Inc. (WRIT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

WRIT Media Group, Inc. is a diversified media and software business whose shares trade on the OTC Markets. The Company’s portfolio of wholly-owned businesses includes Front Row Networks; Amiga Games; Retro Infinity, Inc.; and Pandora Venture Capital. WRIT Media Group is headquartered in Los Angeles, California.

WRIT Media’s operations include digital currency software development, including trading platforms and Blockchain solutions, content production and distribution; and video game distribution by way of mobile platforms. Its Front Row Networks produces and distributes live event programming for international digital broadcast to movie theaters and online streaming.

WRIT’s Amiga Games is a software company. Amiga is restarting the Amiga brand through publishing retro video games on smartphones and tablets. WRIT’s Retro Infinity is a video game distribution site. It publishes video games from Amiga, Atari and other "retro" brands on contemporary smartphones, tablets and consoles.

Additionally, WRIT’s Pandora Venture Capital is a financial technology company. Pandora has an emphasis on its digital currency, Pelecoin, a new generation of digital currency, Blockchain technology solutions, and also the CrypFXPro trading platform. WRIT Media's proprietary CrypStock digital trading platform will provide the technology that will support the creation and trading platform for Pelecoin and other digital currencies.

WRIT Media Group plans to integrate its Pelecoin Blockchain technology into products and applications that can be used to make it as easy to spend digital currencies, cryptocurrencies, and Pelecoin, as it is to spend US Dollars. Through the Company’s acquisition of Pandora Venture Capital, WRIT assumed a skilled management team with backgrounds in payments, telecom, and digital currency.

Recently, WRIT Media Group announced a number of technology innovations within its Pelecoin cryptocurrency system. The Company plans over the next year to enhance its software platform through adding more features and by expanding its ecosystem through new products.

During the past several months, WRIT Media's development team has built the core functionality of its digital currency system. The Company now offers a new feature that enables users to mine four cryptocurrencies at the same time by employing Pelecoin's proprietary mining algorithm software. The core system is complete. The foundation is ready for Pelecoin to expand and become a strong platform suitable for broader adoption, with updated core features and extensive new ones for its ecosystem.

WRIT Media Group, Inc. (WRIT), closed Tuesday’s trading session at $0.0155, up 67.1159%, on 203 volume. The average volume for the last 3 months is 9,338 and the stock's 52-week low/high is $0.006599999/$0.0269.

chart

The QualityStocks Company Corner

The Movie Studio Inc. (OTC: MVES)

The QualityStocks Daily Newsletter would like to spotlight The Movie Studio Inc. (OTC: MVES).

The Movie Studio Inc. (OTC: MVES) is a vertically integrated motion picture production company focused on acquiring, developing, producing and distributing independent motion picture content for worldwide consumption via subscription and advertiser video on demand (SVOD/AVOD), over the top (OTT) platforms, foreign sales and various media devices. The company is currently engaged in establishing its own OTT VOD platform to integrate both its own and aggregated feature film projects, television programming and other media intellectual properties. The Movie Studio is disrupting traditional media content delivery systems with its digital business model of motion picture distribution, and the company intends to create a direct server access platform of its content with geo-fractured territories for worldwide distribution.

The company has launched The Movie Studio App on Google Play and the App Store, enabling users to both view the company’s content and potentially become part of it. The app is in the completion stage, and The Movie Studio is conducting its final beta test of the app’s unique “audition submission” function, leveraging the company’s “Watch Our Movies, Be in Our Movies!” content platform and “Everyone’s a Star” campaign, which will be marketed via social media. Using the app, subscribers can upload a thumbnail photo of themselves along with a selfie video audition submission that showcases them reading character dialog. Audition submissions will then be reviewed by producers for possible participation of the auditionee in upcoming feature films.

The audition submission function provides the subscriber the ability to disrupt traditional motion picture casting and management, enabling access to participation in The Movie Studio’s independent motion picture and media content. At the same time, for the company this significantly reduces capital expenditures associated with those traditional media mechanisms. The Movie Studio’s unique business model capitalizes on the global demand for film content through the production and distribution of its own films while also providing opportunities for direct viewer involvement in its content.

The company operates using a growth-by-acquisition strategy that includes:

  • Purchasing legacy film libraries.
  • Upgrading acquired films to 4K resolution and remonetizing with “new” film content on popular VOD streaming platforms across the internet.
  • Strategic partnerships and media content alignment with other OTT platforms and cross-collateralization of leverageable media assets for worldwide distribution.
  • Producing micro-budget motion picture content with substantial production value utilizing new 4K technology and the company’s extensive legacy resources and unique production process, thereby significantly reducing capital expenditures while allowing for the potential of significant return on investment (ROI) with one successful production.
  • Controlling its revenue streams through server-driven geo-fracturing global territories and its own OTT platform.

Currently, The Movie Studio is producing three upcoming feature films: “Cause and Effect,” “The Last Warhead” and “PEGASUS” — all with completed electronic press kits and pitch decks and fully produced motion picture-quality trailers ready for talent, distribution and financial integration.

The company has been successful in producing, casting and distributing its films on major SVOD platforms without recognizable stars, which reduces capital expenditures. However, The Movie Studio intends to integrate recognizable stars into the productions at value propositions either pre- or post-completion of the intellectual property.

Through successful beta testing, The Movie Studio has monetized film assets on the Amazon, tubi tv, Comcast and Showtime platforms.

The company’s proposed server-based model will provide licensing payment from global territories without third-party distribution fees, which have traditionally been as high as 35%.

Founded in 1961 and formerly known as Destination Television, Inc., the company changed its name to The Movie Studio, Inc. in November 2012. The Movie Studio is headquartered in Fort Lauderdale, Florida.

Cord-Cutting Creates Opportunity for VOD Players

Consumers are no longer content waiting for their favorite programming to come on the air – they expect instant streaming access where and how they want it. This has led to increased “cord cutting,” with consumers severing ties with their traditional pay TV providers in favor of digital streaming services.

With the advent of smart TVs with app integration, consumers can now watch what they want to watch when they want to watch it, fracturing traditional cable bundling mechanisms.

With pay TV usage steadily declining – satellite and cable TV businesses in the United States lost approximately 6 million customers in 2019 alone – streaming platforms are poised to potentially replace traditional pay TV distribution models altogether. Approximately 12,000 U.S. consumers are cutting the cord every day.

As this shift in media delivery continues and as digital devices become more sophisticated and bandwidth increases, VOD platforms have the potential to scale significantly. The Hollywood “streaming wars” of recent years have created an environment in which smaller competitors, like The Movie Studio, are able to emerge as major brands.

The Movie Studio Inc. (OTC: MVES), closed Tuesday’s trading session at $0.027025, even for the day, on 5 volume. The average volume for the last 3 months is 24,655 and the stock's 52-week low/high is $0.009999999/$0.07.

Recent News

chart

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced that it has been awarded two U.S. patents for its industry-leading technology, PrintRite3D(R). According to the update, the patents include: U.S. Application No.: 16/234,333 Titled: Systems and Methods for Additive Manufacturing Operations; and U.S. Application No.: 16/282,004 Titled: Systems and Methods for Measuring Radiated Thermal Energy During an Additive Manufacturing Operation. To view the full press release, visit http://nnw.fm/c8L0R

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Tuesday’s trading session at $2.65, up 17.2566%, on 113,113 volume. The average volume for the last 3 months is 74,329 and the stock's 52-week low/high is $2.18109989/$18.50.

Recent News

chart

Champignon Brands Inc. (CSE: SHRM)

The QualityStocks Daily Newsletter would like to spotlight Champignon Brands Inc. (CSE: SHRM).

Champignon Brands Inc. (CSE: SHRM) was featured in today's edition of the Investorideas.com potcastsCM, cannabis news and stocks to watch plus insight from thought leaders and experts. Listen to the podcast: http://ibn.fm/XW4ql.

Champignon Brands Inc. (CSE: SHRM) is a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind.

Headquartered in Vancouver, British Columbia, Champignon’s team aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

Brands

Champignon’s mushroom-derived consumer packaged goods (CPGs) portfolio includes its flagship brand, Vitality Superteas. Each carefully curated Vitality Supertea formulation was developed with the intent of helping individuals enhance and enrich their wellbeing one cup of mushroom-infused tea at a time.

Also in the portfolio are Nourish Force Supertea, a blend of Reishi Ryobus Tea Mix; Mighty Recharge Supertea, created with Lions Mane Tropical Green Ginseng Tea Mix; and Brain Enhance Supertea, a blend of Cordycep Hibiscus and Berries Tea Mix – all of which are formulated with organic ingredients and chosen for their ability to provide unique health and performance benefits.

Champignon’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom vertical space with a selection of mushroom-infused teas and accessories.

Functional Mushroom Market

Demand for consumer products infused with the nutritional and bioactive benefits of mushrooms is fueling a global market projected to reach $34.3 billion by 2024, growing at a compound annual growth rate of 8.04% from 2019-2024 (ResearchandMarkets), with Europe seen as the fastest growth leader.

According to the market study, in highest demand are products infused with Reishi – a traditional Chinese medicine also known as the “Elixer of Life” and “Mushroom of Immortality – Lions Mane and Cordyceps, followed by other types of medicinal mushrooms.

Advances in Legalization

Legalization of psychedelics for use in medicine is gaining momentum across the United States. Denver, Colorado, and Oakland and Santa Cruz, California, have decriminalized the use of psilocybin, the psychedelic molecule found in various mushrooms, while movements for legalization are gaining ground in Oregon and Iowa, among others. Decriminalize California recently teamed up with the Beckley Foundation to replicate Oakland’s success of decriminalization throughout the state of California.

An increasing number of researchers are turning their attention toward the study of psilocybin as a means to treat otherwise untreatable illnesses. The molecule’s ability to provide landmark treatment options for depression, post-traumatic stress disorder (PTSD), migraines and addiction is gaining widespread acceptance among medical professionals, unicorn investors and accredited institutions.

Potential Applications

Historical data and new scientific studies suggest therapeutic benefits of psychedelics in many areas, including drug addiction, alcoholism, depression, migraines, smoking cessation and post-traumatic stress disorder (PTSD).

The market potential in these areas are significant. To reference just one of the above conditions, the mental health arena has been frequently neglected over the last 30 years, though new research is beginning to further reinforce that psychedelic compounds have the potential to produce more effective treatments than what is currently available.

According to the World Health Organization, 25% of the world’s populous will be afflicted by mental health and/or neurological disorders. Presently, approximately 450 million people currently suffer from such conditions, placing mental disorders among the leading causes of ill-health, productive loss and disability worldwide.

Additionally, PTSD affects approximately 2.2% of the U.S. population; 7.7 million people will have PTSD at some point in their lives. Recent published studies have demonstrated the safety and efficacy of certain psychedelics when administered in a medically supervised and monitored approach.
A renaissance in alternative medicines is emerging, and Champignon has set in motion its strategy to become a key player.

2020 Stealth IP Strategy

Champignon plans to biosynthesize psilocybin within the first three months of conducting laboratory experiments, with the objective of achieving optimized and scaled production of pharmaceutical-grade psilocybin for deployment in clinical settings. This strategy includes:

  • Alternative medicine (psilocybin) IP aggregation
  • Development of cGMP formulations of bioactive compounds extracted from plants and Fungi
  • Drafting of benchmark SOPs (Standard Operating Procedures)
  • Patient aggregation, focusing on veterans

Defining a New Asset Class: Psychedelic-Inspired Medicines

In the third quarter of 2020, Champignon – through clinical trials, a compelling IP portfolio and clinical pipeline and drug development platform – plans to advance its pursuit of treatments underpinned by psychedelic substances. This strategy is broken down into two ties:

  • Non-Hallucinogenic Medicines
    • Microdosing Psilocybin/LSD
    • MDMA, commonly known as ecstasy
  • Hallucinogenic Medicines
    • Psilocybin high dose
    • LSD high dose

Partnerships

Companies worldwide are beginning to incorporate functional mushrooms into their product offerings, taking advantage of growing consumer awareness of known health benefits of the ingredients found in mushrooms.

Champignon in November 2019 entered into a distribution partnership with Eurolife Brands Inc. (CSE: EURO), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics. Under the agreement, Champignon’s branded products are integrated into Eurolife’s e-commerce platform, along with potential distribution opportunities in select brick-and-mortar retail locations in Europe.

Champignon also has an R&D/production formulation agreement with Drip Coffee Social Ltd., located in Nanaimo, British Columbia, which calls for the infusion of Champignon’s proprietary mushroom extract blend into a suite of cold brew coffee products and signature in-house formulations.

Leadership

Gareth Birdsall, CEO, Corporate Secretary and Director
Gareth Birdsall has more than seven years of experience working in diverse agricultural roles such as the cultivation of various fungi, in particular Cordycepes, Reishi, Lions Mane and Chaga. He is an attendee of the British Columbia Institute of Technology, studying marketing management and finance.

Steven Brohman, CPA, CFO
Steven Brohman has more than 10 years of experience working in a variety of roles with public and private companies. He has had extensive training in the audit of publicly traded companies on the TXS, TSX Venture Exchange and OTC markets, and serves as CFO and director of various public and private companies. Brohman has a bachelor’s degree of business administration and obtained his Chartered Professional Accountant designation.

Jerry Habuda, Director
Jerry Habuda brings to Champignon over 35 years of expertise in law enforcement and specialized units. From 1977 to 2012, he served as a police officer with the Toronto Police Department. During his tenure, he was assigned to the Major Crimes Unit, investigating robberies and home invasions. He was assigned to patrol the Toronto Community Housing projects at Jane/Finch to control drug trafficking and gun violence. Habuda was with the Warrant Unit where he tracked down and arrested wanted criminals. From 1993-1997, he was assigned to the Northwest Drug Squad on undercover and surveillance work, executing narcotic search warrants. Between 2002 and 2004, Habuda headed the Street Violence Task Force, a special unit designed to curb gun and drug violence that was terrorizing the city at the time.

Champignon Brands Inc. (CSE: SHRM), closed Tuesday’s trading session at $0.305, up 8.93%.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint (OTCQB: SING) today announced that its Direct Solar America subsidiary has positioned the entire company for success as its first week of virtual sales demonstrated encouraging results. Per the release, SinglePoint has always intended on moving to an entirely online purchase system, and current conditions have acted as a catalyst to implement this vision now. To view the full press release, visit http://nnw.fm/f1OSR

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Tuesday’s trading session at $0.0048, up 10.2181%, on 7,013,477 volume. The average volume for the last 3 months is 4,835,657 and the stock's 52-week low/high is $0.004/$0.021999999.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Tuesday’s trading session at $0.035, off by 13.4734%, on 332,750 volume. The average volume for the last 3 months is 398,392 and the stock's 52-week low/high is $0.0215/$0.3944.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (CIIX) was featured today in the 420 with CNW by CannabisNewsWire. A little over two months after the novel Coronavirus first appeared in Wuhan, China, it has spread to every continent except Antarctica and left over 10,000 people dead in its wake. The World Health Organization has declared the virus a pandemic, and it’s safe to say most of us haven’t experienced anything of this magnitude in our lifetimes. Fearing an outbreak of black plague proportions, most countries have been going into lockdowns to prevent the spread of the virus.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Tuesday’s trading session at $0.1001, off by 9.00%, on 93,084 volume. The average volume for the last 3 months is 60,900 and the stock's 52-week low/high is $0.094999998/$0.50999999.

Recent News

chart

PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA)

The QualityStocks Daily Newsletter would like to spotlight PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA).

Technology provider PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) recently announced that the company is still working with institutional lenders to secure extensive credit facilities that enable consumers to buy, lease and sell vehicles through its cloud-based transaction platform amid the COVID-19 pandemic. To view the full press release, visit http://nnw.fm/TN9ck

A Better Way to Connect and Acquire Vehicles

PowerBand’s mission is to create an online, consumer-directed marketplace that streamlines the interactions among all participants in the automotive industry. It transforms today’s antiquated business model with speed, transparency, access to information and ease of use for consumers and dealers.

Consumers can easily connect with new sources to buy vehicles, network with motivated buyers and sellers, maximize their trade-in values, improve their customer experience. PowerBand’s standardized system and transaction process also increase efficiencies and benefits with hands-on, process-driven, in-store training and support.

Through internal development, acquisitions, joint ventures and strategic partnerships, PowerBand is developing solutions for consumers, dealers, manufacturers, commercial customers and lenders that are poised to transform the trillion-dollar U.S. automotive industry.

The PowerBand Auto Platform

PowerBand’s transaction platform was developed by a team of experienced automotive, technology and finance experts, and has been refined through years of operational experience. Built on the core belief that the consumer prefers to primarily conduct automotive transactions online and avoid interactions with unnecessary middlemen, PowerBand’s product solutions include:

  • Leasing: PowerBand is currently licensed in 33 U.S. states via a majority interest in MUSA Auto Finance LLC, an advanced online leasing technology platform that has transformed the new and used vehicle leasing industry. A partnership with Tesla was recently finalized, making MUSA the only approved, non-captive lease partner for Tesla in the U.S.
  • Inventory and Financing: A partnership with RouteOne LLC, a leading financial platform founded in 2002 by Ally Financial, Ford Motor Credit Co., TD Auto Finance and Toyota Financial Services, allows access to a network of more than 18,000 dealerships and 1,400 financing sources.
  • Auction Platform: PowerBand and its joint-venture partner, D2D Auto Auctions, are developing a direct consumer-to-dealer and a consumer-to-consumer automotive portal, which will provide an innovative alternative to physical dealership and auction locations.
  • LiveNet Auction: An online platform portal that allows dealers to create instant live vehicle auctions to a vast network of the industry’s top used vehicle buyers.
  • MarketPlace Auction: An online listing auction site for buying and selling automotive inventory – ideal for dealers, fleet, OEM and rental companies.
  • Used Vehicle Inspections: An LOI agreement with TÜV NORD Mobility Inc., a German-based global leader in vehicle inspections operating in more than 70 countries, will provide the most comprehensive, certified vehicle inspection reports available in North America. Appointments booked within the platform can be performed nearly anywhere.
  • Product Development: PowerBand’s comprehensive consumer solution, Driveaway, will be a fully transactional consumer marketplace where dealers and consumers can buy, sell, trade-in and finance vehicles, often in seconds, from the comfort of their home.

Automotive’s Growing Markets

The automotive dealership and commercial fleet vehicle auction industry is a $100-billion sector with more than 40 million used vehicles transacted in the U.S. each year. Of those, ten million are sold through auctions. From 2013 to 2017, the growth of online-only auctions far outpaced physical auctions, growing at a 33% compound annual growth rate compared to 2% CAGR at physical auctions.

Automotive leasing is another large, growing and fragmented market, generating approximately $120-billion in annual revenue. As a percentage of vehicle sales, leasing reached 30% in 2018, up from 21% in 2012, and is seen as a substantial opportunity for PowerBand and MUSA Auto Finance. Using proprietary technology and by focusing on high-quality, credit-worthy customers, MUSA grew its automotive lease originations to $182 million.

Disrupting Auto Leasing with MUSA

Legacy solutions are complicated, expensive and slow at processing leases. MUSA’s first-of-its-kind technology platform eliminates third-party decisions and the human capital required in the underwriting process. MUSA’s platform navigates the entire customer experience – underwriting, funding and the delivery process – within minutes. Leases can be approved in seconds.

PowerBand’s acquisition of MUSA brings together two leading-edge companies with the vision to become a one-stop platform for the entire vehicle purchase lifecycle.

Experienced Leadership

PowerBand is led by a collection of automotive veterans with a passion to collectively and positively impact the industry.

  • Kelly Jennings, president and CEO, is the founder of PowerBand Solutions and a franchise dealer owner/operator with more than 27 years of automotive experience. Jennings received General Motor’s Triple Crown Award, Ford Motor Company President’s Award and Honda Canada’s Excellence Award.
  • Darrin Swenson, COO of PowerBand and D2D Auto Auctions/Hunt Automotive Group, has more than 25 years of automotive/auction experience.
  • Jeff Morgan, CEO MUSA, holds over 25 years of experience in the auto finance sector.

 

PowerBand Solutions Inc. (OTCQB: PWWBF), closed Tuesday’s trading session at $0.07, up 8.6181%, on 35,838 volume. The average volume for the last 3 months is 42,789 and the stock's 52-week low/high is $0.038600001/$0.230000004.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of three new members to its Board of Directors. To view the full press release, visit http://nnw.fm/S9Rbz

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Tuesday’s trading session at $2.89, up 27.3128%, on 3,176,794 volume. The average volume for the last 3 months is 8,178,926 and the stock's 52-week low/high is $0.231000006/$7.0300002.

Recent News

chart

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF)

The QualityStocks Daily Newsletter would like to spotlight Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF).

Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW; OTCQB: CANSF) is pleased to announce its financial and operating results for the three months and year ended December 31, 2019. Selected financial and operational information is outlined below and should be read with Willow's audited consolidated financial statements (the "Financial Statements") and management's discussion and analysis (the "MD&A") as of December 31, 2019, which are available on SEDAR at www.sedar.com and on Willow's website at www.willowbio.com. The Company's annual information form (the "AIF") for the year ended December 31, 2019 has also been filed on SEDAR and is available on Willow's website.

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.

The company is headquartered in Calgary, Alberta, Canada.

Biosynthesis Platform

Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.

The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.

Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.

Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.

World-Class Collaboration

Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.

The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.

Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.

Market Opportunity

The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.

The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.

The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.

Capitalization

Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.

Leadership

President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.

Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.

Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.

Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.

Willow Biosciences Inc. (OTCQB: CANSF), closed Tuesday’s trading session at $0.3244, up 29.76%, on 6,425 volume. The average volume for the last 3 months is 8,069 and the stock's 52-week low/high is $0.239999994/$2.1775.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) was highlighted today in a publication from Stock Markets Press, which looked at how Todd Davis, CEO and Chairman of CBD Unlimited, Inc. (OTC PINK: EDXC) has described 2020 in the CBD industry as a ‘shakeout year’ predicting the strength of stronger CBD companies in the competitive landscape for survival.

Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.

A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.

Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.

In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:

  • Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
  • Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
  • Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
  • Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.

Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:

  • Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
  • Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
  • Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
  • R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.

Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Tuesday’s trading session at $0.1501, up 0.525061%, on 750,079 volume. The average volume for the last 3 months is 544,283 and the stock's 52-week low/high is $0.101000003/$1.75.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“Sproutly" or the “Company”) is pleased to provide an update on its business strategy and operations. In light of the significant advancements made by Sproutly and Infusion Biosciences Inc. (“Infusion”) on the APP Technology, as well as recent developments in the cannabis industry in Canada, the Company will now accelerate the commercialization of the APP Technology in Canada. Sproutly is leveraging its technological assets, where it believes it has a competitive advantage, to become a broad supplier of technology-enabled cannabis ingredients to partners and customers to produce truly unique beverages, edibles, and extracts. (the “Business Strategy”).

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed Tuesday’s trading session at $0.0767, up 27.8333%, on 629,487 volume. The average volume for the last 3 months is 162,880 and the stock's 52-week low/high is $0.052999999/$0.850000023.

Recent News

chart

No Borders Inc. (OTC: NBDR)

The QualityStocks Daily Newsletter would like to spotlight No Borders Inc. (NBDR).

No Borders (OTC: NBDR) on Monday announced that the Company has executed an agreement with its existing suppliers in Hong Kong to bring its 15 minute “At Home” Serological COVID-19 test to the USA. According to the update, the brand new “MediDent Supplies 15 Minute Rapid Result Covid-19 Test” is being manufactured by a MediDent Supplies partner with existing U.S. FDA registrations for both the manufacturer and the serological test kit itself. To view the full press release, visit http://cnw.fm/YpMt6

No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.

Different by Design

Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.

The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.

With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.

NBDR Companies

  • No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
  • No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
  • No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
  • No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
  • No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.

 

Leadership

No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.

COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.

CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.

Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.

No Borders Inc. (NBDR), closed Tuesday’s trading session at $0.048, up 6.6667%, on 34,811,413 volume. The average volume for the last 3 months is 2,078,986 and the stock's 52-week low/high is $0.008299999/$0.089000001.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Life Sciences Investor Forum today announced the schedule for its inaugural event for both public and private companies, investors and worldwide industry professionals. The one-day event is kicking off on Thursday, March 26 with the first live webcast at 9:30 AM ET. Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, is scheduled to provide a presentation at 12:00 PM ET on March 26. Per the release, pre-registration is recommended for investors and it is encouraged that they run the online system check to expedite participation and receive event updates. There is no cost to view the live presentations or ask questions. To register now, visit http://cnw.fm/ArT8l. To view the full press release, visit http://cnw.fm/obf1O.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Tuesday’s trading session at $0.30, off by 5.7167%, on 124,805 volume. The average volume for the last 3 months is 117,863 and the stock's 52-week low/high is $0.229499995/$1.34000003.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Tuesday’s trading session at $1.95, up 14.7059%, on 7,603 volume. The average volume for the last 3 months is 18,773 and the stock's 52-week low/high is $0.600600004/$4.0300002.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.